Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Diab Rep. 2016 Aug;16(8):74. doi: 10.1007/s11892-016-0763-1.

What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?

Author information

1
Research Division, 1 Joslin Place, Boston, MA, 02215, USA.
2
Research Division, 1 Joslin Place, Boston, MA, 02215, USA. mary.elizabeth.patti@joslin.harvard.edu.

Abstract

Type 2 diabetes (T2D) is increasing worldwide, making identification of biomarkers for detection, staging, and effective prevention strategies an especially critical scientific and medical goal. Fortunately, advances in metabolomics techniques, together with improvements in bioinformatics and mathematical modeling approaches, have provided the scientific community with new tools to describe the T2D metabolome. The metabolomics signatures associated with T2D and obesity include increased levels of lactate, glycolytic intermediates, branched-chain and aromatic amino acids, and long-chain fatty acids. Conversely, tricarboxylic acid cycle intermediates, betaine, and other metabolites decrease. Future studies will be required to fully integrate these and other findings into our understanding of diabetes pathophysiology and to identify biomarkers of disease risk, stage, and responsiveness to specific treatments.

KEYWORDS:

Insulin resistance; Insulin secretion; Metabolomics; Type 2 diabetes

PMID:
27319324
PMCID:
PMC5441387
DOI:
10.1007/s11892-016-0763-1
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center